97 related articles for article (PubMed ID: 25051113)
21. Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes.
Cawley DB; Simpson DL; Herschman HR
Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3383-7. PubMed ID: 6167984
[TBL] [Abstract][Full Text] [Related]
22. Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers.
Thapa B; Kumar P; Zeng H; Narain R
Biomacromolecules; 2015 Sep; 16(9):3008-20. PubMed ID: 26258607
[TBL] [Abstract][Full Text] [Related]
23. Non-covalent association of folate to lipoplexes: a promising strategy to improve gene delivery in the presence of serum.
Duarte S; Faneca H; de Lima MC
J Control Release; 2011 Feb; 149(3):264-72. PubMed ID: 21044650
[TBL] [Abstract][Full Text] [Related]
24. Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo.
Guo X; Gagne L; Chen H; Szoka FC
J Liposome Res; 2014 Jun; 24(2):90-8. PubMed ID: 24188532
[TBL] [Abstract][Full Text] [Related]
25. Novel targeted liposomes deliver sirna to hepatocellular carcinoma cells in vitro.
Dorasamy S; Narainpersad N; Singh M; Ariatti M
Chem Biol Drug Des; 2012 Nov; 80(5):647-56. PubMed ID: 22783887
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel mono- and bivalent ASGP-R-targeted drug-conjugates.
Petrov RA; Maklakova SY; Ivanenkov YA; Petrov SA; Sergeeva OV; Yamansarov EY; Saltykova IV; Kireev II; Alieva IB; Deyneka EV; Sofronova AA; Aladinskaia AV; Trofimenko AV; Yamidanov RS; Kovalev SV; Kotelianski VE; Zatsepin TS; Beloglazkina EK; Majouga AG
Bioorg Med Chem Lett; 2018 Feb; 28(3):382-387. PubMed ID: 29269214
[TBL] [Abstract][Full Text] [Related]
27. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
Trerè D; Fiume L; De Giorgi LB; Di Stefano G; Migaldi M; Derenzini M
Br J Cancer; 1999 Oct; 81(3):404-8. PubMed ID: 10507763
[TBL] [Abstract][Full Text] [Related]
28. Novel serum-tolerant lipoplexes target the folate receptor efficiently.
Gorle S; Ariatti M; Singh M
Eur J Pharm Sci; 2014 Aug; 59():83-93. PubMed ID: 24769039
[TBL] [Abstract][Full Text] [Related]
29. Spacer Length: A Determining Factor in the Design of Galactosyl Ligands for Hepatoma Cell-Specific Liposomal Gene Delivery.
Mbatha L; Chakravorty S; de Koning CB; van Otterlo WA; Arbuthnot P; Ariatti M; Singh M
Curr Drug Deliv; 2016; 13(6):935-45. PubMed ID: 26906564
[TBL] [Abstract][Full Text] [Related]
30. The pathway of the asialoglycoprotein-ligand during receptor-mediated endocytosis: a morphological study with colloidal gold/ligand in the human hepatoma cell line, Hep G2.
Geuze HJ; Slot JW; Strous GJ; Schwartz AL
Eur J Cell Biol; 1983 Nov; 32(1):38-44. PubMed ID: 6321187
[TBL] [Abstract][Full Text] [Related]
31. Selective gene transfer to hepatocellular carcinoma using homing peptide-grafted cationic liposomes.
Tu Y; Kim JS
J Microbiol Biotechnol; 2010 Apr; 20(4):821-7. PubMed ID: 20467260
[TBL] [Abstract][Full Text] [Related]
32. A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.
Pireddu R; Pibiri M; Valenti D; Sinico C; Fadda AM; Simbula G; Lai F
Int J Pharm; 2018 Feb; 537(1-2):257-267. PubMed ID: 29294323
[TBL] [Abstract][Full Text] [Related]
33. Cationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studies.
Monpara J; Velga D; Verma T; Gupta S; Vavia P
Drug Deliv Transl Res; 2019 Feb; 9(1):106-122. PubMed ID: 30132199
[TBL] [Abstract][Full Text] [Related]
34. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene; 1995 Jul; 159(2):167-74. PubMed ID: 7542617
[TBL] [Abstract][Full Text] [Related]
35. Hydration of surfactant-modified and PEGylated cationic cholesterol-based liposomes and corresponding lipoplexes by monitoring a fluorescent probe and the dielectric relaxation time.
Maitani Y; Nakamura A; Tanaka T; Aso Y
Int J Pharm; 2012 May; 427(2):372-8. PubMed ID: 22348874
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3.
Tran PL; Vigneron JP; Pericat D; Dubois S; Cazals D; Hervy M; DeClerck YA; Degott C; Auclair C
Cancer Gene Ther; 2003 Jun; 10(6):435-44. PubMed ID: 12768188
[TBL] [Abstract][Full Text] [Related]
37. Galactose-functionalized cationic polycarbonate diblock copolymer for targeted gene delivery to hepatocytes.
Ong ZY; Yang C; Gao SJ; Ke XY; Hedrick JL; Yan Yang Y
Macromol Rapid Commun; 2013 Nov; 34(21):1714-20. PubMed ID: 24123359
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides.
Simões S; Slepushkin V; Pires P; Gaspar R; de Lima MP; Düzgüneş N
Gene Ther; 1999 Nov; 6(11):1798-807. PubMed ID: 10602375
[TBL] [Abstract][Full Text] [Related]
39. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy.
Xu W; Cao L; Chen L; Li J; Zhang XF; Qian HH; Kang XY; Zhang Y; Liao J; Shi LH; Yang YF; Wu MC; Yin ZF
Clin Cancer Res; 2011 Jun; 17(11):3783-93. PubMed ID: 21527564
[TBL] [Abstract][Full Text] [Related]
40. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation.
Fumoto S; Kawakami S; Ito Y; Shigeta K; Yamashita F; Hashida M
Mol Ther; 2004 Oct; 10(4):719-29. PubMed ID: 15451456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
